Synthesis and preliminary in vitro evaluation of polymeric dicarboxylato- and dihydroxylatoplatinum(II) chelates as antiproliferative agents

Polymers for Advanced Technologies

Volumn 13, Issue 10-12, 2002, Pages 884-894

  Neuse, Eberhard W ^a   Mphephu, Ntshengedzeni ^a   Netshifhefhe, Humphrey M ^a   Johnson, Mark T ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Antiproliferative activity; Cell culture tests; Macromolecular platinum conjugates

Indexed keywords

CHELATION; CHEMOTHERAPY; DISEASES; DRUG PRODUCTS; SYNTHESIS (CHEMICAL);

PHARMACOLOGICAL DEFICIENCIES;

ORGANIC POLYMERS;

DRUG DELIVERY; POLYMER; SYNTHESIS;

EID: 0036825593     PISSN: 10427147     EISSN: None     Source Type: Journal    
DOI: 10.1002/pat.241     Document Type: Article

References (27)

1. Ringsdorf H. Structure and properties of pharmacologically active polymers. J. Polym. Sci. Polym. Symp. 1975; 51: 135.
2. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Contr. Rel. 2000; 65: 271.
3. Lloyd JB. The taxonomy of lysosomes and related structures. Subcellular Biochemistry, vol. 27: Biology of the Lysosome, Lloyd JB (ed.). Plenum Press: New York, 1996, p. 1. See also p. 361.
4. Matthews S, Pouton CW, Threadgill MD. Macromolecular systems for chemotherapy and magnetic resonance imaging. Adv. Drug Deliv. Rev. 1996; 18: 219.
5. Takakura Y, Mahato RI, Nishikawa M, Hashida M. Control of pharmacokinetic profiles of drug-molecule conjugates. Adv. Drug Deliv. Rev. 1996; 19: 377.
6. Putnam D, Kopeček J. Polymer conjugates with anticancer activity. Adv. Polym. Sci. 1996; 122: 55.
7. Duncan R, Spreafico F. Polymer conjugates. Pharmacokinetic considerations for design and development. Clin. Pharmacokinet. 1994; 27: 290.
8. Duncan R, Kopeček J. Soluble synthetic polymers as potential drug carriers. Adv. Polym. Sci. 1984; 57: 51.
9. Hoes CJT, Feijen J. The application of drug polymer conjugates in chemotherapy. In Drug Carrier Systems, Roerdink FHD, Kroon AM (eds). Wiley: Chichester, 1989, p. 57.
10. Waud WR. Platinum complexes. In Cancer Chemotherapeutic Agents, Foye WO (ed.). American Chemical Society: Washington, DC, 1995, p. 121.
11. Heim ME. Platinum and non-platinum complexes in clinical trials. Current status and new developments. In Metal Complexes in Cancer Chemotherapy, Keppler BK (ed.). VCH: Weinheim, 1993, p. 10.
12. Hambley TW. The influence of structure on the activity and toxicity of platinum anti-cancer drugs. Coord. Chem. Rev. 1997; 166: 181.
13. Reedijk J. Improved understanding in platinum antitumour chemistry. Chem. Commun. 1996; 801.
14. Kelland LR. New platinum antitumor complexes. Crit. Rev. Oncol./Hematol. 1999; 15: 191.
15. Neuse EW. Platinum coordination compounds in cancer research and chemotherapy. S. Afr. J. Sci. 1999; 95: 509.
16. Neuse EW. Carrier-bound platinum and iron compounds with carcinostatic properties. Polym. Adv. Technol. 1998; 9: 786.
17. Hoeschele JD, Farrell N, Turner WR, Rithner CD. Synthesis and characterization of diastereomeric (substituted iminodiacetato)(1,2-diaminocyclohexane) platinum(II) complexes. Inorg. Chem. 1988; 27: 4106.
18. Neri P, Antoni G. ∀,∃-Poly(2-hydroxyethyl)-DL-aspartamide. Macromol. Synt. 1982; 8: 25.
19. Bariyanga J, Johnson MT, Mmutlane EM, Neuse EW. A polymeric malonic acid derivative with drug-binding functionality. Submitted for publication to S. Afr. J. Sci.
20. Johnson MT, Komane LL, Mphephu N, Netshifhefhe HM, Neuse EW. Polymeric drug carriers functionalized with pair-wise arranged dicarboxyl, dihydroxyl, or carboxyl-hydroxyl groups for platinum chelation. Submitted for publication to S. Afr. J. Sci.
21. Meirim MG, Neuse EW, Caldwell G. Aliphatic polyamides prepared by ester-amine polycondensation as potential drug carrier systems. J. Appl. Polym. Sci. 1999; 73: 2143.
22. Drobnik J, Saudek V, Vlašak J, Kálal J. Polyaspartamide - a potential drug carrier. J. Polym. Sci. Polym. Symp. 1979; 66: 65.
23. Caldwell G, Neuse EW, Perlwitz AG. Water-soluble polyamides as potential drug carriers. IX. Polyaspartamides grafted with amine-terminated poly(ethylene oxide) chains. J. Polym. Sci. 1997; 66: 911; and preceding papers in this series.
24. Caldwell G, Neuse EW, van Rensburg CEJ. Cytotoxicity of selected water-soluble polymer-cis-diaminedi-chloroplatinum (II) conjugates against the human HeLa cancer cell line. J. Inorg. Organometal. Polym. 1997; 7: 217.
25. Shen W-C, Beloussow K, Meirim MG, Neuse EW, Caldwell G. Antiproliferative activity of polymer-bound, monoamine-coordinated platinum complexes against LNCaP human metastatic prostate adenocarcinoma cells. J. Inorg. Organometal. Polym. 2000; 10: 51.
26. Li Y, Kwon GS. Micelle-like structures of poly-(ethylene oxide)-block-poly(2-hydroxyethyl aspartamide)-methotrexate conjugates. Colloids and surfaces B: Biointerfaces, 1999; 16: 217.
27. Van Niekerk E, O'Sullivan JF, Joone GK, van Rensburg CEJ. Invest. New Drugs, 2001; 19: 211.